Search research articles
Contact Us
Filters
Showing results (21-30 of 115) with videos related to
Page
of 12
Sort By:
The Lancet. Infectious Diseases
|
August 2, 2018
WHO preferred product characteristics for new vaccines against tuberculosis
Lewis K Schrager, Padmapriyadarsini Chandrasekaran, Bernard H Fritzell, et al.
Plos One
|
December 16, 2014
Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children
Ally Olotu, Frederic Clement, Erik Jongert, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 5, 2002
Monophosphoryl lipid A activates both human dendritic cells and T cells
Jamila Ismaili, Joëlle Rennesson, Ezra Aksoy, et al.
Journal of Tropical Pediatrics
|
August 30, 2005
Dissociation between tuberculin skin test and in vitro IFN-gamma responses following neonatal BCG vaccination
Martin O C Ota, Tessa Goetghebuer, Johan Vekemans, et al.
The Lancet. HIV
|
December 2, 2019
HIV immunoprophylaxis: preparing the pathway from proof of concept to policy decision and use
Johan Vekemans, William Snow, Patricia E Fast, et al.
Malaria Journal
|
July 11, 2014
Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes
Kazutoyo Miura, Erik Jongert, Bingbing Deng, et al.
Twin Research : the Official Journal of the International Society for Twin Studies
|
September 27, 2003
Delay in motor development of twins in Africa: a prospective cohort study
Tessa Goetghebuer, Martin O C Ota, Bunja Kebbeh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 24, 2021
Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial
Michiko Asano, Hiroshi Okada, Yohji Itoh, et al.
Vaccine
|
February 4, 2018
Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics
Johan Vekemans, Vasee Moorthy, Brigitta Giersing, et al.
Vaccine
|
November 18, 2019
Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations
Johan Vekemans, Michael James Brennan, Mark Hatherill, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 115) with videos related to
Sort By:
Page
of 12
The Lancet. Infectious Diseases
|
August 2, 2018
WHO preferred product characteristics for new vaccines against tuberculosis
Lewis K Schrager, Padmapriyadarsini Chandrasekaran, Bernard H Fritzell, et al.
Plos One
|
December 16, 2014
Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children
Ally Olotu, Frederic Clement, Erik Jongert, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 5, 2002
Monophosphoryl lipid A activates both human dendritic cells and T cells
Jamila Ismaili, Joëlle Rennesson, Ezra Aksoy, et al.
Journal of Tropical Pediatrics
|
August 30, 2005
Dissociation between tuberculin skin test and in vitro IFN-gamma responses following neonatal BCG vaccination
Martin O C Ota, Tessa Goetghebuer, Johan Vekemans, et al.
The Lancet. HIV
|
December 2, 2019
HIV immunoprophylaxis: preparing the pathway from proof of concept to policy decision and use
Johan Vekemans, William Snow, Patricia E Fast, et al.
Malaria Journal
|
July 11, 2014
Effect of ingested human antibodies induced by RTS, S/AS01 malaria vaccination in children on Plasmodium falciparum oocyst formation and sporogony in mosquitoes
Kazutoyo Miura, Erik Jongert, Bingbing Deng, et al.
Twin Research : the Official Journal of the International Society for Twin Studies
|
September 27, 2003
Delay in motor development of twins in Africa: a prospective cohort study
Tessa Goetghebuer, Martin O C Ota, Bunja Kebbeh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 24, 2021
Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial
Michiko Asano, Hiroshi Okada, Yohji Itoh, et al.
Vaccine
|
February 4, 2018
Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics
Johan Vekemans, Vasee Moorthy, Brigitta Giersing, et al.
Vaccine
|
November 18, 2019
Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations
Johan Vekemans, Michael James Brennan, Mark Hatherill, et al.
Page
of 12